ACSC - Resident Leadership Day

June 20, 2017 in Ottawa, Ontario

Resident Leadership Day - new this year!

Click here to register (add this day to your ACSC registration or register for it separately)


The SOGC and APOG have co-developed a one-day program specifically tailored to the needs and interests of ob/gyns in training. The Resident Leadership Day will offer residents an opportunity to interact with Canada’s leading ob/gyn experts, as well as peers from medical programs across the country.

In the morning session, Setting Up for Success, residents will gain practical advice to prepare for their future careers as ob/gyns. Guest speakers will present Little BIG Talks on career preparation, career advice, resume building, and practice management. These talks will be followed by a rotation of round table discussions in smaller groups, allowing participants to ask their questions directly to experts who have already seen the path to success in the field of obstetrics and gynaecology.

In the afternoon, residents will have a choice between two hands-on courses focused on topics that are essential to building a career in ob/gyn – laparoscopy and ultrasound. These hands-on courses are designed specifically to meet the educational needs of residents and are an excellent opportunity to get feedback from experts and to practice vital techniques.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Biography

Dr. Olga Bougie MD

Ottawa ON
Dr. Bougie attainted her medical degree at Queen’s University and completed her residency in Obstetrics and Gynecology at the University of Ottawa. She is currently completing an AAGL Fellowship in Minimally Invasive Gynecology at the Universityof Ottawa, as well as a Masters of Public Health, Clinical Epidemiology at Harvard University. Her clinical interests include endoscopic surgery and complex benign gynecologic cases. Her research interests include endometriosis and patient-centered outcomes in gynecology.

Disclosure

1. I do not have an affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization.

2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).